Dr. Aaron D. Goldberg, MD, PhD, is a board-certified hematologist and medical oncologist specializing in the care of patients with leukemia and myelodysplastic syndrome at Memorial Sloan Kettering Cancer Center. He holds board certifications in hematology, medical oncology, and internal medicine, and works as part of a multidisciplinary team of physicians and nurses dedicated to delivering comprehensive, advanced care for patients and their families. Trained as both a clinician and a scientist, Dr. Goldberg brings a dual perspective to patient care, combining attentive, personalized medicine with a rigorous molecular approach to understanding each patient's disease and determining the most effective treatment strategy.
Why they are a top doctor
Research papers · PubMed
63
Published, peer-reviewed work, the clearest public measure of expertise in a specialty.
Cited by other doctors
8.1k
How often other doctors and researchers build on their work.
Known for
Immunotherapy and chemotherapy
The distinction that sets them apart from other leukemia specialists.
Background
Education
Medical school: MD, Weill Cornell Medical College · PhD, Rockefeller University
Residency: Internal Medicine - Brigham and Women’s Hospital
Fellowship: Hematology/Medical Oncology - Memorial Sloan Kettering Cancer Center
Board certifications: Internal Medicine · Hematology · Medical Oncology
Awards
American Society of Hematology Fellow Scholar Award in Clinical Research (2018)
Advancing Science through Pfizer Investigator Research Exchange (ASPIRE) Oncology/Hematology Clinical Research Award (2017)
American Society of Clinical Oncology Young Investigator Award (2017)
Memorial Sloan Kettering Cancer Center Chief Hematology Fellow (2016)
Resident Mentor Award, Brigham and Women’s Hospital (2014)
Franklyn Ellenbogen Prize in Hematology-Oncology, Weill Cornell Medical College (2011)